Stuttgart, Germany--(Newsfile Corp. - June 7, 2016) - Medicus Homecare Inc. (OTC Pink: MDCRE) (the "Company") is pleased to inform its shareholders that it has recently filed its Quarterly Report on Form 10-Q on June 3, 2016 for the quarter ended June 30, 2015. The financial statements of the Company for the three month period ended June 30, 2015 showed $2,346,320 ($3,707,154 for the six months) was generated from the medical in-home care services provided in Germany. After the costs of providing the services, the Company had net revenues of $521,184 ($743,514 for the six months) and net income of $165,787 ($280,828 for the six months).

Dr. Orhan Karahodza, the President and a Director of the Company, stated, "We are extremely pleased to finally have completed our quarterly report for the quarter ended June 30, 2015. We would like to thank our shareholders for their support during the transition to a public company".

Mr. Nowek, CFO, says "the Company is well on its way to completing the two remaining overdue quarterly reports for the quarters ended September 30, 2015 and March 31, 2016 and annual report of the year ended December 31, 2015. All information for those reports is currently being reviewed by the Company's accountants and independent auditor (scheduled for June 2016) and the next first filing is targeted for June 2016".

Mr. Nowek thinks that once these filings are finalized the Company has a unique opportunity for growth through natural expansion and acquisition.

ABOUT MEDICUS HOMECARE INC.

The Company offers medical in-home care services in Germany including ventilation for patients that suffer from debilitating diseases such as Amyotrophic Lateral Sclerosis (ALS), Muscular Dystrophy (MD), Guillain-Barre syndrome (GBS), and Chronic Obstructive Pulmonary Disease (COPD). Other services provided by the Company include acute post-patient care, respiration optimization and monitoring of long-term home respiration.

For additional information regarding the Company, please visit www.medicushomecareinc.com, or email info@medicus-24.de or telephone +49 157 894 69537.

On behalf of the Board,

Dr. Orhan Karahodza
Presidentand Director

Notice Regarding Forward-Looking Statements

This news release may contain forward-looking statements (within the meaning of applicable securities laws) relating to business of the Company and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions. These statements are based on the Company's expectations, estimates, forecasts and projections and include statements relating to trading of the warrants. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company's regulatory filings available on EDGAR or in the Company's Form 10-KT for the fiscal year ended December 31, 2014, filed on December 28, 2015, and in the Company's Form 10-Q for the quarter ended June 30, 2015. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. The Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.